Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in New Aquitaine.
5A-QUIT-N
1 other identifier
interventional
4,505
1 country
1
Brief Summary
The investigators are conducting a pragmatic cluster randomized trial in stepped-wedge of which objectives are to evaluate the effectiveness and the conditions of effectiveness of an organizational strategy for smoking cessation - 5A-QUIT-N - among pregnant women in New Aquitaine (NA), by using and optimizing existing resources
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 2, 2022
CompletedFirst Posted
Study publicly available on registry
May 2, 2022
CompletedStudy Start
First participant enrolled
October 3, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2026
ExpectedOctober 25, 2023
October 1, 2023
2.7 years
March 2, 2022
October 24, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Tobacco abstinence at delivery
The point prevalence of abstinence at delivery, which is the proportion of women reporting abstinence from smoking for at least 7 days at delivery. This criterion is well documented in the literature assessing tobacco use. It has the advantage of detecting the delayed effects of an intervention and can be easily extrapolated.
At delivery (smoking status of the previous 7 days)
Secondary Outcomes (15)
Average number of cigarettes smoked at inclusion
At inclusion
Average number of cigarettes smoked at postpartum
6 months and 1 year after delivery
Attempts to reduce tobacco consumption
1 to 3 days after delivery
Attempts to quit smoking
1 to 3 days after delivery
Continuous abstinence
1 to 3 days after delivery
- +10 more secondary outcomes
Study Arms (2)
5A-QUIT-N intervention
EXPERIMENTALThe 5A-QUIT-N intervention can be defined as multilevel, i.e., it is based on a territorial organization with expected results at the level of professional practice (structuring of practices around the 5A method) and therefore of the care of pregnant women who smoke tobacco. This project is based on three strategic axes: * A gradation of the care offer * Personalized care by developing specific treatment paths * Coordination of territorial resources to support pregnant women in quitting smoking. These elements will make it possible to propose a partnership-based, multi-professional, coordinated and integrated approach to the territory, supported by the technical resources and expertise available in the territory. It invites a majority of non-specialized actors to invest in the process of supporting pregnant women in quitting smoking, multiplying and potentiating their actions with this population.
5A-QUIT-N control
NO INTERVENTIONUsual care in the care of pregnant women who smoke tobacco.
Interventions
This project is based on three strategic axes: * A gradation of the care offer allowing to adapt the means and resources mobilized on the territory * Personalized care by developing specific treatment paths based on the risk factors and/or vulnerabilities of the pregnant woman * Coordination of territorial resources to support pregnant women in quitting smoking These three key elements will make it possible to propose a partnership-based, multi-professional, coordinated and integrated approach to the territory, supported by the technical resources and expertise available in the territory. It invites a majority of non-specialized actors to invest in the process of supporting pregnant women in quitting smoking, multiplying and potentiating their actions with this population.
Eligibility Criteria
You may qualify if:
- \- Territory of maternity attractiveness in New Aquitaine
- All institutions, structures and organizations and health professionals likely to participate in the follow-up of pregnant women
- All institutions, structures and organizations and health professionals specializing in addictology or tobaccoology
- \- All pregnant women who have smoked tobacco (at least 2 times a week, for at least 1 week) during the pregnancy (including the period when she was unaware of the pregnancy)
- Have given birth in a New Aquitaine maternity hospital,
- Reside in New Aquitaine
- To have been followed for the pregnancy in the territory of the maternity of delivery
- To have used tobacco during (at least 2 times a week, for at least 1 week) the pregnancy (including the period when she was unaware of the pregnancy)
- Be over 18
- Have given free, informed and express consent
You may not qualify if:
- Pilot territory (territory of attractiveness of the Arcachon maternity hospital)
- Not speaking French,
- Have COVID during delivery
- Use only electronic cigarettes,
- Under legal protection (guardianship, curatorship, safeguard of justice)
- Women giving birth under X
- Women giving birth to a stillborn baby
- Women having made a denial of pregnancy
- Women who have their child in neonatal intensive care
- Women who have been fully monitored for their pregnancy outside of New Aquitaine
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux, Hôpital Saint-André
Bordeaux, 33000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
François Alla, Prof
University Hospital, Bordeaux
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 2, 2022
First Posted
May 2, 2022
Study Start
October 3, 2022
Primary Completion
May 31, 2025
Study Completion (Estimated)
May 31, 2026
Last Updated
October 25, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share